No Data
Altimmune Expands Board Amid Late-Stage Drug Development
Express News | Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors
Press Release: Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors
TD Cowen raised the Global sales forecast for weight loss drugs until 2030, stating that "Nautilus" will continue to dominate the market.
TD Cowen Inc expects that as Eli Lilly and Co and Novo-Nordisk A/S continue to dominate, GLP-1 weight-loss drug global sales will reach 139 billion dollars by 2030, an increase of over 38% from previous forecasts.
Earnings Preview: Altimmune to Report Financial Results on February 27
Altimmune to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on February 27, 2025
